Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis-Reference-Cited by-同舟云学术

Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis

Published:2022-08-09 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Memon Rahat A,Hamdani Syed Shah Qasim,Usama Ali,Aisha FNU,Kundi Hayan,Mathavan Mohit,Khalid Malaika,Khan Areeba

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference26 articles.

1. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study;Wolf PA;Stroke,1991

2. Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study;Go AS;JAMA,2001

3. Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study);Sam C;Am J Cardiol,2004

4. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart RG;Ann Intern Med,2007

5. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society;January CT;Circulation,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin in Patients with Venous Thromboembolism using Real-World Data: A Systematic Review and Meta-Analysis;American Journal of Cardiovascular Drugs;2024-09-10

2. Plasma apixaban concentrations and thrombin generation assay parameters in response to dose reduction for atrial fibrillation;British Journal of Clinical Pharmacology;2024-08-15

3. Comparison of Effectiveness and Safety of Direct-Acting Oral Anticoagulants and Vitamin K Agonists in Patients With Atrial Fibrillation and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis;Cureus;2024-04-02